Jennifer Chien
Corporate Officer/Principal en RHYTHM PHARMACEUTICALS, INC. .
Fortuna: 296 897 $ al 31/03/2024
Perfil
Jennifer L.
Chien is currently the Executive Vice President & Head-North America at Rhythm Pharmaceuticals, Inc. Prior to this, she worked as the Vice President & Head-Genetic Diseases at Genzyme Therapeutics Ltd.
from 2017 to 2020.
She also briefly served as the Chief Commercial Officer at Krystal Biotech, Inc. in 2020.
Ms. Chien received her graduate degree from Harvard University and her undergraduate degree from Massachusetts Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/03/2024 | 6 852 ( 0.01% ) | 296 897 $ | 31/03/2024 |
Cargos activos de Jennifer Chien
| Empresas | Cargo | Inicio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09/11/2020 |
Antiguos cargos conocidos de Jennifer Chien.
| Empresas | Cargo | Fin |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 16/10/2020 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01/01/2020 |
Formación de Jennifer Chien.
| Harvard University | Graduate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| KRYSTAL BIOTECH, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Chien
